The members of the Lymphoma Tumour Group would appreciate your feedback concerning any of these policies. Contact any member or the chairman with your questions or suggestions. Intravenous radiographic contrast studies are contra-indicated and may cause renal injury. 1.1.2 Staging BCCA uses the widely accepted staging system for myeloma developed by Durie and Salmon. All patients should receive the immunizations recommended in Appendix III 2.
Chemotherapy is the treatment of choice.
Even though a cure is not possible, chemotherapy often offers satisfactory palliation. Such patients should be discussed with a member of the Bone Marrow Transplant Team before treatment is initiated. Please discuss enrollment with any medical oncology member at a BCCA Center. Presently the optimal duration of pamidronate treatment is unknown but most benefit probably takes place during the first several months of administration. Until more information becomes available pamidronate should be given to all patients with myeloma until active treatment of the disease is abandoned.